Study Design of a Phase 2/3 Randomized Controlled Trial of Dupilumab in Adults with Bullous Pemphigoid: LIBERTY-BP ADEPT
Advances in Therapy · 2024-07 · 41 (7) · 2991-3002
DOI: 10.1007/s12325-024-02810-3 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Advances in Therapy, online erschienen am 05.03.2024. Verfasst von Dédée F Murrell und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, St George Hospital, University of New South Wales, Sydney, NSW, Australia. d.murrell@unsw.edu.au. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Pemphigoid, Bullous. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Sanofi, Regeneron Pharmaceuticals, University of New South Wales.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, St George Hospital, University of New South Wales, Sydney, NSW, Australia. d.murrell@unsw.edu.au.
- The Church, 17 Kensington St, Kogarah, NSW, 2217, Australia. d.murrell@unsw.edu.au.
- Rouen University Hospital and INSERM 1234, Normandy University, Rouen, France.
- Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
- Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, PA, USA.
- Department of Dermatology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
Förderung
- Sanofi
- Regeneron Pharmaceuticals
- University of New South Wales
Zitieren
APA
Murrell, D. F., Joly, P., Werth, V. P., Ujiie, H., Worm, M., Mangold, A. R., Avetisova, E., Maloney, J., Laws, E., Mortensen, E., Dubost-Brama, A., & Shabbir, A. (2024). Study Design of a Phase 2/3 Randomized Controlled Trial of Dupilumab in Adults with Bullous Pemphigoid: LIBERTY-BP ADEPT. Advances in Therapy, 41(7), 2991-3002. https://doi.org/10.1007/s12325-024-02810-3
Vancouver
Murrell DF, Joly P, Werth VP, Ujiie H, Worm M, Mangold AR, et al. Study Design of a Phase 2/3 Randomized Controlled Trial of Dupilumab in Adults with Bullous Pemphigoid: LIBERTY-BP ADEPT. Advances in Therapy. 2024;41(7):2991-3002. doi:10.1007/s12325-024-02810-3
BibTeX
@article{Murrell2024,
author = {Murrell, Dédée F and Joly, Pascal and Werth, Victoria P and Ujiie, Hideyuki and Worm, Margitta and Mangold, Aaron R and Avetisova, Elena and Maloney, Jennifer and Laws, Elizabeth and Mortensen, Eric and Dubost-Brama, Ariane and Shabbir, Arsalan},
title = {Study Design of a Phase 2/3 Randomized Controlled Trial of Dupilumab in Adults with Bullous Pemphigoid: LIBERTY-BP ADEPT},
journal = {Advances in Therapy},
year = {2024},
volume = {41},
number = {7},
pages = {2991--3002},
doi = {10.1007/s12325-024-02810-3}
}
EUVIMED